KCAS Bio will be attending BioVaria in Munich, on April 27-28, 2026. This event connects leading tech transfer professionals and academic innovators with start-ups and representatives from the global biotech and pharma industry.
Supporting Biologics Drug Development
KCAS Bio supports small and large molecule drug development across preclinical and clinical stages with integrated bioanalytical and biomarker solutions. Our capabilities include support for advanced modalities, with expertise in pharmacokinetics, biomarkers, immunogenicity, and advanced flow cytometry to enable robust, decision-ready data.
Connect with KCAS Bio in Munich
We invite you to connect with KCAS Bio to discuss how our bioanalytical expertise can support your research and development programs. Whether you are addressing technology transfer challenges, advancing complex modalities, or preparing for clinical development, our teams are ready to support your objectives.
Contact us to schedule a meeting.